US Patent Issued to Alkermes Pharma Ireland on Sept. 29 for "Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia" (Ohio, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,237, issued on Sept. 29, was assigned to Alkermes Pharma Ireland Ltd. (Dublin).

"Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia" was invented by Wilfredo Morales (Morrow, Ohio), Tarek A. Zeidan (Lexington, Mass.), Renato A. Chiarella (Cambridge, Mass.), Steven G. Wright (Madeira, Ohio) and Jason M. Perry (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m2/g; and crystals of aripiprazole lauro...